| |
|
|
|
La Jolla Pharmaceutical Company  
|
|
8.37 -0.01 (-0%) |
10-16 16:00 |
|
Open: |
8.3 |
Pre close: |
8.38 |
Target:
|
11.83 
|
|
High: |
8.58 |
Low: |
8.27 |
Resistance:
|
10.13
11.38
|
|
Volume: |
135,702 |
Market Cap: |
227M |
Support:
|
8.10
6.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.43
|
MACD |
MACD(12,26):
|
-0.39  |
|
MA(20): |
8.98 |
Signal(12,26,9): |
-0.33 |
|
MA(100): |
9.08 |
Stochastic Oscillator |
%K(14,3):
|
17.42 |
|
MA(250): |
9.17 |
%D(3): |
14.50 |
|
Average Volume(K) |
3-Month: |
31617
|
52-Week |
High:
|
18.04 |
|
10-Days: |
21364 |
Low: |
5.01 |
|
RSI |
RSI(14):
|
33.44 |
Change(%): |
-52.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.920 |
Return on Equity (ttm) |
-307.1 |
Shares Out. (M) |
27.13 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
-40.9 |
Shares Float (M) |
14.98 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
-0.14 |
% Held by Insiders |
6.08 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
258.0 |
% Held by Institutions |
104.64 |
|
Forward EPS |
-2.611 |
Gross Profit (p.s.) |
-3.925 |
Shares Short (K) |
5270 |
|
Book Value (p.s.) |
-0.610 |
EBITDA (p.s.) |
-5.171 |
P/E |
-1.41 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-13.72 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-118.15 |
P/S |
344057728.00 |
|
Operating Margin |
-816.09 |
Levered Free Cash Flow
(M) |
-66.88 |
P/CF |
-1.92 |
|
|
|
|
|
|
